相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The biological role and regulation of versican levels in cancer
Carmela Ricciardelli et al.
CANCER AND METASTASIS REVIEWS (2009)
Positive crosstalk between ERK and p38 in melanoma stimulates migration and in vivo proliferation
Yeriel Estrada et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer
Suniti Misra et al.
CONNECTIVE TISSUE RESEARCH (2008)
EGFR family: Structure physiology signalling and therapeutic targets
Antony W. Burgess
GROWTH FACTORS (2008)
All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells
Rong-Hua Tao et al.
JOURNAL OF CELL SCIENCE (2008)
Suppression of human colon cancer tumors in nude mice by siRNA CD44 gene therapy
Venkateswaran Subramaniam et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2007)
Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Breast tumor kinase (Protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells
Julie Hanson Ostrander et al.
CANCER RESEARCH (2007)
High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma
Matti Pukkila et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and-2
Hosami Harada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis
Laia Miquel-Serra et al.
LABORATORY INVESTIGATION (2006)
Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer
Steven J. Wang et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms V0 and V1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells
D Nikitovic et al.
IUBMB LIFE (2006)
Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding
G Tzircotis et al.
JOURNAL OF CELL SCIENCE (2005)
The interaction of versican with its binding partners
YJ Wu et al.
CELL RESEARCH (2005)
V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential
M Serra et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells
S Ghatak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells
C Gordon-Thomson et al.
MELANOMA RESEARCH (2005)
Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis
R Pirinen et al.
HUMAN PATHOLOGY (2005)
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer
S Suwiwat et al.
CLINICAL CANCER RESEARCH (2004)
CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion
LYW Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Versican in epithelial ovarian cancer: Relation to hyaluronan, clinicopathologic factors and prognosis
K Voutilainen et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Distinct interaction of versican/PG-M with hyaluronan and link protein
K Matsumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation
C Stove et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Versican: a versatile extracellular matrix proteoglycan in cell biology
TN Wight
CURRENT OPINION IN CELL BIOLOGY (2002)
Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1
EP McDermott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Versican is differentially expressed in human melanoma and may play a role in tumor development
M Touab et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro
JM Lemire et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
CD44-mediated uptake and degradation of hyaluronan
W Knudson et al.
MATRIX BIOLOGY (2002)
Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185HER2 and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth
LYW Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
SB203580 promote EGF-stimulated early morphological differentiation in PC12 cell through activating ERK pathway
LG New et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2001)
Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways
VK Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Divergent roles for Ras and Rap in the activation of p38 mitogen-activated protein kinase by interleukin-1
EM Palsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
